您当前所在位置:首页 > 宣传资料 > 新品上市
序号 标题 次数 作者 发布时间
73081 Azide-PEG3-Val-Cit-PAB-MMAF,叠氮-三聚乙二醇-Val-Cit-PAB-MMAF 70 WYQ 2024-12-19
73082 Arm-DOTA-B72.3 71 h 2024-12-19
73083 cas:1884577-99-4 Boc-Val-Ala-PAB 86 zyl 2024-12-19
73084 (Lys(DOTA)4)BVD15 DOTA偶联神经肽Y(NPY)类似物 120 h 2024-12-19
73085 1801838-28-7,Mc-vc-PAB-SN38,化合物MC-VC-PAB-SN38 79 kx 2024-12-19
73086 DOTA-PPI 1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)-官能化的聚(丙烯亚胺)(PPI)糖树枝状分子 78 h 2024-12-19
73087 CAS: 863971-17-9,MC-Val-Cit-PAB-MMAF 99 WYQ 2024-12-19
73088 cas:1884577-99-4 Boc-Val-Ala-PAB 116 zyl 2024-12-19
73089 DBCO-PEG4-vc-PAB-MMAE, ADC试剂 102 kx 2024-12-19
73090 1884578-00-0,Boc-PEG4-Val-Ala-PAB-PNP,ADC定制 102 wyh 2024-12-19
73091 DOTA-Peg-Cpa-c[DCys-Aph(Cbm)-DTrp-Lys-Thr-Cys]-2Nal-NH2 71 h 2024-12-19
73092 DOTA-2.5D DOTA-胱氨酸结肽(knottins)2.5D和2.5F 85 h 2024-12-19
73093 二苯并环辛炔-四聚乙二醇-VAL-ALA-PAB,ADC定制 109 wyh 2024-12-19
73094 Hz220(DOTA-Lys(IR dye 650)-PEa(4)-[D-Phe(6)DOTA偶联的GRPr拮抗剂 85 h 2024-12-19
73095 Azido-PEG4-MMAE,抗体药物偶联物(ADCs) 115 WYQ 2024-12-19
73096 1626359-62-3,SPDB-DM4, ADC试剂 72 kx 2024-12-19
73097 Acid-PEG4-Val-Cit-PAB-MMAE,包含PEG链和MMAE等部分 80 WYQ 2024-12-19
73098 cas:159857-70-2,MC-Val-Cit-Doxorubicin,ADC定制 100 wyh 2024-12-19
73099 DOTA-(D)Phe(1)-Tyr(3) 76 h 2024-12-19
73100 cas:1884577-99-4 Boc-Val-Ala-PAB 117 zyl 2024-12-19
73101 FAM-amido hexamethylene carbamate-PAB-Cit-Val-Alkyne 112 WYQ 2024-12-19
73102 DOTA-l-Nal3-octreotide DOTA-l-nal3-奥曲肽 73 h 2024-12-19
73103 CAS: 2762518-86-3 ,NHS ester-PEG4-Val-Cit-PAB-MMAE 86 WYQ 2024-12-19
73104 cas:2873452-49-2 ; MC-EVCit-PAB-MMAE,ADC定制 101 wyh 2024-12-19
73105 CAS: 2762519-08-2 endo-BCN-PEG4-Val-Cit-PAB-MMAE,内末端二苯卡宾吡啶甲酸乙酯聚乙二醇4个单元赖氨酸缬氨酸丙氨酸天冬氨酸 127 WYQ 2024-12-19
73106 cas:863971-24-8,Mc-MMAE ,马来酰亚胺基己酰-单甲基澳瑞他汀 E 155 kx 2024-12-19
73107 DOTA-(AEEA)2-BN DOTA-(AEEA)2-铃蟾肽 79 h 2024-12-19
73108 cas:2259318-55-1 , DBCO-(PEG2-VC-PAB-MMAE)2,ADC定制 86 wyh 2024-12-19
73109 cas:1394238-91-5 Fmoc-Val-Ala-PAB 108 zyl 2024-12-19
73110 CAS: 2285373-84-2 Ethyl (S)-1-((1-((4-((((4-nitrophenoxy)carbonyl) oxy)methyl)phenyl)amino)-1-oxo-5-ureidopenta n-2-yl)carbamoyl)cyclobutane-1-carboxylate 132 WYQ 2024-12-19
73111 Azido-Phenyl-Amido-SS-Sulfo-NHS Ester, ADC试剂 87 kx 2024-12-19
73112 DOTA-βala-K-NOTA-BBN(7-14)NH2 98 h 2024-12-19
73113 DBCO-PEG3-acetic-Val-Cit-PAB,主要用于合成抗体偶联药物(ADC) 86 WYQ 2024-12-19
73114 Mal-PEG4-Val-Ala-PAB-PNP,ADC定制 64 wyh 2024-12-19
73115 cas:330970-70-2 Alloc-Val-Ala-OH 81 zyl 2024-12-19
73116 DOTA-somatostatin receptor analogs DOTA生长抑素受体类似物 66 h 2024-12-19
73117 CAS: 2754384-60-4,DBCO-(PEG)3-VC-PAB-MMAE 67 WYQ 2024-12-19
73118 Fmoc-Gln(Trt)-PAB-OH, ADC试剂 107 kx 2024-12-19
73119 CAS: 2994332-18-0 ,DBCO-C4-Val-Cit-PABC-PNP,二苯并环辛炔-C4-缬氨酸-瓜氨酸-PABC-对硝基苯基磷酸酯 77 WYQ 2024-12-19
73120 cas:159857-60-0,Fmoc-Lys(MMt)-OH,N-[(9H-芴-9-基甲氧基)羰基]-N'-[(4-甲氧基苯基)二苯基甲基]-L-赖氨酸 163 kx 2024-12-19
73121 DBCO-PEG3-Val-Cit-PAB-PNP,二苯并环辛炔-三聚乙二醇-缬氨酸-瓜氨酸-PAB-PNP 109 WYQ 2024-12-19
73122 NOTA-anti-HER2 NOTA标记抗人表皮生长因子受体2型(HER2)纳米体 107 h 2024-12-19
73123 cas:186023-44-9 Fmoc-Ala-Pro-OH 96 zyl 2024-12-19
73124 TCO-PEG4-Val-Cit-PAB-PNP,反式环辛烯-四聚乙二醇-缬氨酸-瓜氨酸-PAB-PNP 78 WYQ 2024-12-19
73125 Boc-Val-Cit CAS:870487-08-4 95 zyl 2024-12-19
库存查询